<DOC>
	<DOCNO>NCT00644579</DOCNO>
	<brief_summary>As many 85 % renal transplant patient may suffer viral wart high degree treatment resistance . Promising result hLAC ( human lactalbumin complex lipid ) point beneficial effect without noticeable side effect bLAC ( bovine lactalbumin complex lipid ) . The aim first clinical trial bLAC show proof concept treatment cutaneous wart lesion hand and/or foot local administration bLAC two dose group immune suppress , kidney transplant patient .</brief_summary>
	<brief_title>bLAC - Treatment Cutaneous Warts Immune Suppressed , Kidney Transplanted Patients</brief_title>
	<detailed_description />
	<mesh_term>Warts</mesh_term>
	<criteria>Cutaneous wart inger and/or palm and/or toe and/or soles foot Common wart mosaic wart , diagnose experienced dermatologist Solitary wart lesion 2 lesion per patient Lesions present 6 month Men woman , age 18 History kidney transplantation immune suppressive therapy transplant Concomitant immune suppressive therapy stable 6 month prior randomization Agreement patient allow photograph take used part trial data documentation ( 2 centre ) Women childbearing potential must negative pregnancy test screening must use adequate contraception Ability comply requirement trial Written inform consent Verruca plana lesion Suspected allergy milk verify serum analysis IgE towards cow milk Breastfeeding Any local medication purpose wart treatment target area 4 week prior randomization treatment period Concomitant treatment wart therapy two week prior randomization trial period Intolerance towards bovine alphalactalbumin , oleic acid excipient formulation Known HIV infection current uncontrolled infection Any chronic acute skin condition susceptible interfering evaluation drug effect trial Participation investigational trial use investigational drug within 30 day prior inclusion trial Any health problem accord Investigator 's clinical judgment make patient unsuitable inclusion trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>wart</keyword>
	<keyword>cutaneous</keyword>
	<keyword>transplant</keyword>
	<keyword>Cutaneous wart immune suppress , kidney transplant patient</keyword>
</DOC>